Adele Viguera, MD

• NIMH K23 Career Development Award (K23 MH-11609), focused on The Course of Bipolar Disorder in Pregnancy and the Postpartum Period, 1999-2004
• R01 from National Institute of Mental Health for a multisite collaborative study with Emory School of Medicine on Bipolar Disorder in Pregnancy: Predictors of Morbidity (Collaborative Grant: R01 MH 071762 [Viguera]; R01 MH 071531[Newport]), 2005-2010  
• New Investigators Program, National Institute of Mental Health, New Clinical Drug Evaluation Unit (NCDEU), 1998 Awardee
• Scientific peer reviewer for NIH SCOR Centers on Women’s Health, Bethesda, Md., March 8-9, 2007
• Massachusetts General Hospital Women’s Health Research Day, 2006 Awardee

• Master's Degree in Public Health, quantitative methods, Harvard School of Public Health

• Dr. Viguera has had a very successful track record securing support to study important research questions in reproductive psychiatry. Early in her academic career, she was the recipient of an NIMH K23 Career Development Award (K23 MH-11609), focused on the Course of Bipolar Disorder in Pregnancy and the Postpartum Period. 
• She has received additional awards from private foundations including  two consecutive National Alliance for Research in Schizophrenia and Depression (NARSAD) Young Investigator Research Awards for the study of Neonatal Outcome Following Exposure to Lithium. 
• In 2004, she received a two-year Harvard Medical School Scholars in Medicine Fellowship Claflin Award for a project entitled, Screening for Antenatal Bipolar Disorder Associated with Maternal Morbidity and Adverse Neonatal Outcome. The body of research laid the groundwork for an R01.
• In 2005, she was awarded an R01 grant from the National Institute of Mental Health for a multisite collaborative study with Emory School of Medicine on Bipolar Disorder in Pregnancy: Predictors of Morbidity (Collaborative Grant: R01 MH 071762 [Viguera]; R01 MH 071531[Newport]).

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2025-12-10, Dr. Viguera has reported the financial relationships with the companies listed below.

Consulting and/or Speaking. Dr. Viguera receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• UpToDate (a Wolters Kluwer Brand)

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.